In this podcast, Daniel R. Kuritzkes, MD, talks about HIV resistance in the context of pre-exposure prophylaxis (PrEP) use, how common it is, and how PrEP might influence subsequent therapies. More at: www.consultant360.com/infectious-diseases.

In this podcast, Laszlo L. Mechtler, MD, from the Dent Neurologic Institute, discusses the role of neuroimaging in diagnosing headache disorders, which patient populations are indicated for neuroimaging, and some of the common questions he receives about neuroimaging for headache disorders. More at: www.consultant360.com/neurology.

In this podcast, MeiLan Han, MD, discusses influenza vaccination for patients with chronic obstructive pulmonary disease (COPD), the challenges associated with vaccinating this population, and the conversations you should be having with your patients. More at: www.consultant360.com/pulmonology.

In this podcast, Vincent Martin, MD, from the University of Cincinnati, defines migraine triggers, discusses the pathophysiology of migraine triggers, and explains how to clinically manage migraine triggers. More at: www.consultant360.com/neurology.

In this podcast, Aaron Waxman, MD, PhD, discusses the role of exercise hemodynamics in the diagnosis and treatment of pulmonary hypertension and the types of exercise that are best for patients with pulmonary hypertension. More at: www.consultant360.com/pulmonology.

In this podcast, Nicole Loo, MD, from Texas Liver Institute, and Christopher Chen, PhD, from Texas Biomedical Research Institute, discuss the current management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis, obesity as a risk factor for NAFLD, the importance of screening and prevention, and more.

Joan T. Merrill, MD, from the Oklahoma Medical Research Foundation, discusses her research presented at the Annual European Congress of Rheumatology that evaluated different serologic features to encourage more entry in lupus clinical trials of individuals with active disease, and more.

A new study analyzed how a combination of atomoxetine and oxybutynin affects obstructive sleep apnea (OSA) severity. In this podcast, one of the study’s authors, Luigi Taranto-Montemurro, MD, from Harvard Medical School and Brigham and Women's Hospital, provides insight on his findings and what they mean for the future of pharmacotherapy for OSA. For more, click here: https://www.consultant360.com/pulmonology

Jonathan Spergel, MD, PhD, from Children’s Hospital of Philadelphia, discusses the current management of milk-induced eosinophilic esophagitis (EoE) among children, his study that evaluated epicutaneous immunotherapy as a potential treatment option, and more.

In this podcast, Christian Osadnik, PhD, discusses his team's latest research on the effects of pulmonary rehabilitation programs on comorbid depression and anxiety in patients with chronic obstructive pulmonary disease. More at: www.consultant360.com/pulmonology.